# 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer

> **NCT01658813** · PHASE2 · COMPLETED · sponsor: **Western Regional Medical Center** · enrollment: 18 (actual)

## Conditions studied

- Gastrointestinal Cancer Metastatic
- Renal Cell Cancer Metastatic
- Non Small Cell Lung Cancer Metastatic

## Interventions

- **DRUG:** 5-Fluorouracil and Interferon

## Key facts

- **NCT ID:** NCT01658813
- **Lead sponsor:** Western Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01658813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01658813, "5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01658813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*